BMRN financials
BioMarin (BMRN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BMRN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $3.22B | $2.48B | $533.48M | $348.90M | 1.80 |
| 2024 | $2.85B | $2.27B | $484.21M | $426.86M | 2.21 |
| 2023 | $2.42B | $1.89B | $185.77M | $167.65M | 0.88 |
| 2022 | $2.10B | $1.59B | $160.97M | $141.56M | 0.75 |
| 2021 | $1.85B | $1.38B | -$82.34M | -$64.08M | -0.35 |
| 2020 | $1.86B | $1.34B | -$43.44M | $854.03M | 4.53 |
- BMRN revenue was $3.22B in fiscal 2025, net income $348.90M.
Updated 2026-11-03 02:04 UTC